ES2196180T3 - Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada. - Google Patents
Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada.Info
- Publication number
- ES2196180T3 ES2196180T3 ES96933878T ES96933878T ES2196180T3 ES 2196180 T3 ES2196180 T3 ES 2196180T3 ES 96933878 T ES96933878 T ES 96933878T ES 96933878 T ES96933878 T ES 96933878T ES 2196180 T3 ES2196180 T3 ES 2196180T3
- Authority
- ES
- Spain
- Prior art keywords
- sustained release
- narcotics
- analgesics
- antagonists
- supply system
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 238000013268 sustained release Methods 0.000 title abstract 2
- 239000012730 sustained-release form Substances 0.000 title abstract 2
- 229940035676 analgesics Drugs 0.000 title 1
- 239000000730 antalgic agent Substances 0.000 title 1
- 239000004081 narcotic agent Substances 0.000 title 1
- 230000002035 prolonged effect Effects 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 230000000202 analgesic effect Effects 0.000 abstract 1
- 230000003533 narcotic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53675095A | 1995-09-29 | 1995-09-29 | |
| US58827296A | 1996-01-18 | 1996-01-18 | |
| US08/630,205 US5716631A (en) | 1995-09-29 | 1996-04-10 | Long acting narcotic analgesics and antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2196180T3 true ES2196180T3 (es) | 2003-12-16 |
Family
ID=27415224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96933878T Expired - Lifetime ES2196180T3 (es) | 1995-09-29 | 1996-09-25 | Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0859597B1 (https=) |
| AT (1) | ATE236616T1 (https=) |
| AU (1) | AU7244696A (https=) |
| CA (1) | CA2233280A1 (https=) |
| DE (1) | DE69627365T2 (https=) |
| ES (1) | ES2196180T3 (https=) |
| WO (1) | WO1997011681A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6251436B1 (en) | 1995-09-29 | 2001-06-26 | L.A.M. Pharmaceutical Corporation | Drug preparations for treating sexual dysfunction |
| US5897880A (en) * | 1995-09-29 | 1999-04-27 | Lam Pharmaceuticals, Llc. | Topical drug preparations |
| US5952006A (en) * | 1995-09-29 | 1999-09-14 | L.A.M. Pharmaceuticals, Llc | Drug preparations for treating impotency |
| US5900420A (en) * | 1997-06-19 | 1999-05-04 | Cole; William L. | Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| US6143325A (en) * | 1998-06-05 | 2000-11-07 | Bristol-Myers Squibb Company | Nefazodone dosage form |
| US20020177626A1 (en) | 2001-01-19 | 2002-11-28 | Cook Graham D. | Treatment of sleep disturbances |
| DE10153673B4 (de) | 2001-06-18 | 2005-04-07 | Native Instruments Software Synthesis Gmbh | Automatische Erzeugung von musikalischen Scratch-Effekten |
| DE10358749A1 (de) | 2003-12-12 | 2005-07-14 | Lts Lohmann Therapie-Systeme Ag | Darreichungsform zur Bekämpfung von primären Kopfschmerzen |
| CN104244925B (zh) * | 2012-03-07 | 2017-03-29 | 马林克罗特有限公司 | 盐酸氢吗啡酮溶液的提高的稳定性 |
| US9155734B2 (en) | 2012-03-07 | 2015-10-13 | Mallinckrodt Llc | Stability of hydromorphone hydrochloride solutions |
| AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
| IT201800001890A1 (it) * | 2018-01-25 | 2019-07-25 | Fidia Farm Spa | Composizioni farmaceutiche per il trattamento del dolore postoperatorio |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2542616B1 (fr) * | 1983-03-17 | 1987-07-31 | Unilever Nv | Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel |
| SE8900586L (sv) * | 1989-02-21 | 1990-08-22 | Pharmacia Ab | Komposition och foerfarande foer att foerhindra adhesion mellan kroppsvaevnader |
| US5143724A (en) * | 1990-07-09 | 1992-09-01 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
| EP0516026A1 (en) * | 1991-05-28 | 1992-12-02 | Takeda Chemical Industries, Ltd. | Hydrogel and method of producing same |
| US5356629A (en) * | 1991-07-12 | 1994-10-18 | United States Surgical Corporation | Composition for effecting bone repair |
-
1996
- 1996-09-25 CA CA002233280A patent/CA2233280A1/en not_active Abandoned
- 1996-09-25 EP EP96933878A patent/EP0859597B1/en not_active Expired - Lifetime
- 1996-09-25 AU AU72446/96A patent/AU7244696A/en not_active Abandoned
- 1996-09-25 DE DE69627365T patent/DE69627365T2/de not_active Expired - Fee Related
- 1996-09-25 WO PCT/US1996/015293 patent/WO1997011681A1/en not_active Ceased
- 1996-09-25 AT AT96933878T patent/ATE236616T1/de not_active IP Right Cessation
- 1996-09-25 ES ES96933878T patent/ES2196180T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0859597B1 (en) | 2003-04-09 |
| DE69627365T2 (de) | 2004-02-12 |
| DE69627365D1 (de) | 2003-05-15 |
| CA2233280A1 (en) | 1997-04-03 |
| EP0859597A1 (en) | 1998-08-26 |
| AU7244696A (en) | 1997-04-17 |
| ATE236616T1 (de) | 2003-04-15 |
| EP0859597A4 (https=) | 1998-10-07 |
| WO1997011681A1 (en) | 1997-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2196180T3 (es) | Sistema de suministro de liberacion sostenida y analgesicos de narcoticos y antagonistas de accion prolongada. | |
| DE69636104D1 (de) | Orale pharmazeutische Zusammensetzung mit verzögerter Wirkstofffreigabe von Protonenpumpen-Hemmern | |
| GR960100179A (el) | Συσκευη διαδερμικης χορηγησης των φεντανιλ και σουφεντανιλ με ηλεκτρομεταφορα. | |
| IL159766A0 (en) | A sustained release oral dosage form of a hydromorphone | |
| TR200002786T2 (tr) | Meloksikam için yeni galenik bir formülasyon. | |
| TR199901669T2 (xx) | Erkeklerdeki ereksiyon probleminin tedavisi i�in gerekli dozaj �ekilleri ve metod. | |
| AP2000001949A0 (en) | 4-Benzyl piperidine alkysulfoxide heterocycles and their use as subtype-selective NMDA receptor antagonists. | |
| EP1762236A3 (en) | Formulations of alpha adrenergic receptor antagonists and their uses | |
| CA2033122A1 (en) | Anti-inflammatory analgesic patch | |
| NO982580L (no) | Nye taxoider, deres fremstilling samt farmas°ystiske preparater inneholdende taxoidene | |
| NO20001829D0 (no) | Forsinket total frigivelse av magetarmavleveringsmedikament | |
| CY1114011T1 (el) | Φαρμακευτικη στοματικη δοσολογικη μορφη που περιλαμβανει ενα συνδυασμο ενος οπιοειδους αγωνιστη και ενος οπιοειδους ανταγωνιστη | |
| ATE548029T1 (de) | Wirkstoffabgabevorrichtung mit verzögerter freisetzung | |
| CA2239352A1 (en) | Injectable quinolone formulations | |
| BR9912827A (pt) | Composições tópicas compreendendo um analgésico opióide e um antagonista de nmda | |
| FI965021L (fi) | Bentsimidatsolijohdannaisia, joilla on dopaminergistä vaikutusta keskushermostossa | |
| FR2769915B1 (fr) | Derives d'indazole tricycliques, leur preparation et leur application en therapeutique | |
| TR199801871A3 (tr) | Bifenilsulfonilsiyanamidler üretim yöntemi ve ilaç olarak kullanimlari. | |
| TR200001102T2 (tr) | İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları. | |
| BRPI0012553B8 (pt) | pastilha contendo cloridrato de ambroxol, seu processo de preparação e seu uso | |
| MY133169A (en) | Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect | |
| CH691791A8 (de) | Pharmazeutische komposition gegen alkoholmissbrauch und mit notroper wirkung. | |
| HU9700661D0 (en) | Use of alpha-1-adrenoreceptor antagonists for profilacting and treating cancer | |
| EE03205B1 (et) | Ropivakaiini kasutamine valuvaigistina kasutatava ravimpreparaadi valmistamiseks | |
| ATE218881T1 (de) | Pharmazeutische zusammensetzung mit mutiertem tyrosin 353 ezrin |